Kentucky House Bill 163

---

Spectrum: Partisan Bill (Republican 14-0)
Status: Introduced on January 5 2024 - 25% progression
Action: 2024-01-05 - to Committee on Committees (H)
Pending: House Committee On Committees Committee
Text: Latest bill text (Introduced) [PDF]

Amend KRS 214.450 to define "COVID-19 vaccine" or "mRNA vaccine"; amend KRS 214.452 to require blood establishments to test for COVID-19 antibodies, evidence of lipid nanoparticles, and spike protein; require the administrator of any blood establishment to inquire on the donor history questionnaire whether a donor has received a COVID-19 vaccine or mRNA vaccine; require a donor to provide the name of the manufacturer of the COVID-19 vaccine the donor received; establish deferral periods for donors who have received a live attenuated COVID-19 vaccine or for donors who do not know the manufacturer of the COVID-19 vaccine the donor received, and establish deferral periods for donors who have received a diagnosis of COVID-19 or are displaying symptoms of COVID-19; amend KRS 214.458 to require blood establishments to include on the label for blood collected the laboratory test results for COVID-19.

AN ACT relating to blood donation.

Rep. Jennifer Henson Decker [R]	Rep. Emily Callaway [R]	Rep. Stephanie Dietz [R]	Rep. Daniel Fister [R]
Rep. David Hale [R]	Rep. Mary Imes [R]	Rep. DJ Johnson [R]	Rep. Matt Lockett [R]
Rep. Shawn McPherson [R]	Rep. Kimberly Moser [R]	Rep. Rebecca Raymer [R]	Rep. Nancy Tate [R]
Rep. Timmy Truett [R]	Rep. Richard White [R]

Date	Chamber	Action
2024-01-05	House	to Committee on Committees (H)
2024-01-05	House	introduced in House

Type	Source
Summary	https://apps.legislature.ky.gov/record/24RS/hb163.html
Text	https://apps.legislature.ky.gov/recorddocuments/bill/24RS/hb163/orig_bill.pdf